0001178913-23-003157.txt : 20230914 0001178913-23-003157.hdr.sgml : 20230914 20230914170338 ACCESSION NUMBER: 0001178913-23-003157 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230913 FILED AS OF DATE: 20230914 DATE AS OF CHANGE: 20230914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taitel Haya CENTRAL INDEX KEY: 0001979599 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38556 FILM NUMBER: 231255743 MAIL ADDRESS: STREET 1: KIRYAT HADASSAH, MINRAV BUILDING STREET 2: 5TH FLOOR CITY: JERUSALEM STATE: L3 ZIP: 9112002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Entera Bio Ltd. CENTRAL INDEX KEY: 0001638097 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: KIRYAT HADASSAH, MINRAV BUILDING STREET 2: FIFTH FLOOR CITY: JERUSALEM STATE: L3 ZIP: 9112002 BUSINESS PHONE: 972-2-532-7151 MAIL ADDRESS: STREET 1: KIRYAT HADASSAH, MINRAV BUILDING STREET 2: FIFTH FLOOR CITY: JERUSALEM STATE: L3 ZIP: 9112002 4 1 zk2330300.xml X0508 4 2023-09-13 0 0001638097 Entera Bio Ltd. ENTX 0001979599 Taitel Haya KIRYAT HADASSAH, MINRAV BUILDING, 5TH FLOOR JERUSALEM L3 9112002 ISRAEL 1 0 0 0 0 Stock Option (right to buy) 0.809 2023-09-13 4 A 0 33368 0 A 2033-06-06 Ordinary Shares, par value NIS 0.0000769 per share 33368 33368 D This grant of options was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on June 6, 2023, subject to approval by the Company's shareholders, which was obtained on September 13, 2023. The options vest ratably on an annual basis over a three-year period that commenced on June 6, 2023. /s/ Dana Yaacov-Garbeli, Attorney-in-Fact 2023-09-14